Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

Amylyx Pharmaceuticals has announced positive results from the trial, indicating sustained improvements with AMX0035 in ...

Response Pharmaceuticals has initiated subject enrolment for a Phase II trial of its drug candidate RDX-002, designed to ...

Clesrovimab is a single-dose extended half-life monoclonal antibody developed as a passive immunisation for the prevention of RSV. Credit: Sergiy Palamarchuk ...